Shuttle Pharmaceuticals Holdings Inc (NASDAQ:SHPH) experienced a dramatic surge on Friday, with shares climbing 27.38% to $4.815 by 11:02 a.m. EDT. The sharp move came after its subsidiary, United Dogecoin, announced the acquisition of its first Dogecoin miners and the securing of a hydroelectric data center site, marking a significant pivot from its former biopharmaceutical focus.
Trading volume exploded to approximately 21.7 million shares, far exceeding the 65-day average of 311,064 and representing a turnover roughly 70 times the norm. This volume also equates to about 34 times the number of post-split common shares outstanding, highlighting intense investor interest in the micro-cap stock.
United Dogecoin's Mining Expansion
United Dogecoin revealed it has purchased ElphaPex DG1+ miners, each rated at 14.4 GH/s, with the fleet expected to begin operations in approximately 60 days. The company also secured a hydroelectric site that delivers power at $0.064 per kilowatt hour, a competitive rate that could support long-term mining profitability.
Ryan Trasolini, co-chief executive of Shuttle and founder of United Dogecoin, stated, "We are quickly ramping up operations" and confirmed that miners should be online "in approximately 60 days." He added that the company is exploring data center and power-generation sites in Idaho and Alberta for both Dogecoin mining and AI hosting, emphasizing, "Our objective is to build a durable digital infrastructure platform rather than simply operate mining equipment."
Capital Structure and Dilution Risks
Despite the positive news, Shuttle's capital structure presents significant risks for investors. Following the completion of the United Dogecoin merger, the company issued 8,000 Series B-1 preferred shares convertible into approximately 32.3 million common shares before the planned reverse split. Additionally, up to 118.0 million pre-funded warrants were set aside for United Dogecoin holders, depending on milestones and stockholder votes. Taking the pending one-for-10 reverse split into account, this could result in about 15.0 million potential new shares, according to company filings and Reuters calculations.
The deal also included a $9.55 million private placement, with PIPE preferred shares convertible into about 9.3 million common shares before any split, and buyers could receive up to 31.5 million pre-funded warrants if all three milestones are met.
Financial Challenges and Outlook
Shuttle Pharmaceuticals was financially strained before its pivot to cryptocurrency. In the quarter ending March 31, the company reported a net loss of $2.2 million, no revenue, cash holdings of $1.09 million, and a working-capital deficit of $5.8 million. The filing stated that these conditions cast substantial doubt on Shuttle's ability to continue as a going concern.
The company's mining plan targets up to 3,000 ElphaPex Scrypt rigs, aiming for approximately 43,200 GH/s if fully installed. Mined Dogecoin and Litecoin will be held as long-term treasury assets.
Investors are now weighing the potential of Shuttle's digital infrastructure strategy against the substantial dilution and cash burn risks. The stock's extraordinary volume and price action reflect a speculative bet on whether the mining operation can deliver before financial pressures mount.
